Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.51 - $0.93 $118,621 - $216,309
-232,591 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.84 - $1.71 $702 - $1,429
836 Added 0.36%
232,591 $210,000
Q4 2021

Feb 14, 2022

SELL
$1.59 - $2.38 $57,192 - $85,608
-35,970 Reduced 13.44%
231,755 $355,000
Q3 2021

Nov 12, 2021

BUY
$1.69 - $2.89 $177,651 - $303,793
105,119 Added 64.65%
267,725 $536,000
Q2 2021

Aug 16, 2021

BUY
$2.64 - $6.32 $429,279 - $1.03 Million
162,606 New
162,606 $429,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $32M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.